MiR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 2, 2014, Pages 165-174

  Weldon, Sinead ^a   McNally, Paul ^b   McAuley, Danny F ^a   Oglesby, Irene K ^c   Wohlford Lenane, Christine L ^d   Bartlett, Jennifer A ^d   Scott, Christopher J ^e   McElvaney, Noel G ^c   Greene, Catherine M ^c   McCray, Paul B ^d   Taggart, Clifford C ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d UNIVERSITY OF IOWA   (United States)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cystic fibrosis; Epithelium; MicroRNA; Protease

Indexed keywords

CATHEPSIN S; INTERFERON REGULATORY FACTOR 1; LEUKOCYTE ELASTASE; MICRORNA 31; BIOLOGICAL MARKER; CATHEPSIN; IRF1 PROTEIN, HUMAN; MICRORNA; MIRN31 MICRORNA, HUMAN; PEPTIDE HYDROLASE; PROTEINASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS LUNG DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG FIBROSIS; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; CHEMISTRY; DOWN REGULATION; EPITHELIUM; GENETICS; INFANT; ISOLATION AND PURIFICATION; LUNG LAVAGE; METABOLISM; MICROBIOLOGY; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT MUCOSA;

CYSTIC FIBROSIS; EPITHELIUM; MICRORNA; PROTEASE;

ADOLESCENT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CATHEPSINS; CELL LINE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INTERFERON REGULATORY FACTOR-1; MICRORNAS; PEPTIDE HYDROLASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84906922269     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201311-1986OC     Document Type: Article

References (53)

1. Birrer P, McElvaney NG, Rüdeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150:207-213.
2. Stick SM. The first 2 years of life: implications of recent findings. Curr Opin Pulm Med 2009;15:615-620.
3. Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, Murray CP, Stick SM. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013;368:1963-1970.
4. Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EWFW, Bush A, Davies JC. Airway remodelling in children with cystic fibrosis. Thorax 2007;62:1074-1080.
5. Wielpütz MO, Puderbach M, Kopp-Schneider A, Stahl M, Fritzsching E, Sommerburg O, Ley S, Sumkauskaite M, Biederer J, Kauczor H-U, et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2014;189:956-965.
6. Regamey N, Jeffery PK, Alton EWFW, Bush A, Davies JC. Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 2011;66:624-629.
7. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, Robertson CF, Ranganathan SC, Sly PD, Stick SM. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012;67:509-516.
8. Sagel SD, Wagner BD, Anthony MM, Emmett P, Zemanick ET. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am J Respir Crit Care Med 2012;186: 857-865.
9. Weldon S, McNally P, McElvaney NG, Elborn JS, McAuley DF, Wartelle J, Belaaouaj A, Levine RL, Taggart CC. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol 2009;183: 8148-8156.
10. Guyot N, Butler MW, McNally P, Weldon S, Greene CM, Levine RL, O'Neill SJ, Taggart CC, McElvaney NG. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. J Biol Chem 2008;283: 32377-32385.
11. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006;20:543-556.
12. Cheng XW, Shi G-P, Kuzuya M, Sasaki T, Okumura K, Murohara T. Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication. Circulation 2012;125: 1551-1562.
13. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB, O'Neill S, McElvaney NG. Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J Immunol 2003;171:931-937.
14. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis 2004;190:1245-1253.
15. Martin SL, Moffitt KL, McDowell A, Greenan C, Bright-Thomas RJ, Jones AM, Webb AK, Elborn JS. Association of airway cathepsin B and S with inflammation in cystic fibrosis. Pediatr Pulmonol 2010;45: 860-868.
16. Naudin C, Joulin-Giet A, Couetdic G, Plé siat P, Szymanska A, Gorna E, Gauthier F, Kasprzykowski F, Lecaille F, Lalmanach G. Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis. PLoS ONE 2011;6:e25577.
17. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem 1992;267:7258-7262.
18. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102: 576-583.
19. Brömme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, Peters C, Thomas DY, Storer AC, Vernet T. Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. J Biol Chem 1993;268: 4832-4838.
20. Novinec M, Grass RN, Stark WJ, Turk V, Baici A, Lenarcic B. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem 2007;282:7893-7902.
21. Beers C, Burich A, Kleijmeer MJ, Griffith JM, Wong P, Rudensky AY. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J Immunol 2005;174:1205-1212.
22. Haerteis S, Krappitz M, Bertog M, Krappitz A, Baraznenok V, Henderson I, Lindström E, Murphy JE, Bunnett NW, Korbmacher C. Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S. Pflugers Arch 2012;464:353-365.
23. Lecaille F, Naudin C, Sage J, Joulin-Giet A, Courty A, Andrault P-M, Veldhuizen RAW, Possmayer F, Lalmanach G. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. Int J Biochem Cell Biol 2013;45: 1701-1709.
24. Oei E, Kalb T, Beuria P, Allez M, Nakazawa A, Azuma M, Timony M, Stuart Z, Chen H, Sperber K. Accessory cell function of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004;287: L318-L331.
25. Storm van's Gravesande K, Layne MD, Ye Q, Le L, Baron RM, Perrella MA, Santambrogio L, Silverman ES, Riese RJ. IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J Immunol 2002;168:4488-4494.
26. Weldon S, Elborn JS, Scott CJ, Taggart CC. A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease. J Cyst Fibros 2010; 9:S45.
27. Weldon S, McNally P, McAuley DF, Scott CJ, Mall MA, Randell SH, Wohlford-Lenane C, Bartlett JA, McCray PB, Taggart CC. WS9.5 CF epithelial cells are a source of pulmonary cathepsin S via increased IRF-1. J Cyst Fibros 2012;11:S20.
28. Karp PH, Moninger TO, Weber SP, Nesselhauf TS, Launspach JL, Zabner J, Welsh MJ. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol 2002;188:115-137.
29. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
30. Gruenert DC, Basbaum CB, Welsh MJ, Li M, Finkbeiner WE, Nadel JA. Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus. Proc Natl Acad Sci USA 1988;85: 5951-5955.
31. Douglas TA, Brennan S, Gard S, Berry L, Gangell C, Stick SM, Clements BS, Sly PD. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J 2009;33:305-311.
32. Kos J, Sekirnik A, Kopitar G, Cimerman N, Kayser K, Stremmer A, Fiehn W, Werle B. Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br J Cancer 2001; 85:1193-1200.
33. Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, Keshavjee S, Lennox KA, Jacobi AM, Rose SD, et al. A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA 2012;109:13362-13367.
34. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG, Greene CM. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 2010;184: 1702-1709.
35. Williams AS, Eynott PR, Leung S-Y, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF. Role of cathepsin S in ozoneinduced airway hyperresponsiveness and inflammation. Pulm Pharmacol Ther 2009;22:27-32.
36. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853-858.
37. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
38. Grosshans H, Filipowicz W. Molecular biology: the expanding world of small RNAs. Nature 2008;451:414-416.
39. Ramachandran S, Karp PH, Osterhaus SR, Jiang P, Wohlford-Lenane C, Lennox KA, Jacobi AM, Praekh K, Rose SD, Behlke MA, et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol 2013;49:544-551.
40. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C, Srivastava M, Pollard HB, Biswas R. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem 2011;286:11604-11615.
41. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szá sz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009;137: 1032-1046.
42. Xu N, Meisgen F, Butler LM, Han G, Wang X-J, Söderberg-Nauclé r C, Sta hle M, Pivarcsi A, Sonkoly E. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase. J Immunol 2013;190:678-688.
43. Wang H-W, Huang T-S, Lo H-H, Huang P-H, Lin C-C, Chang S-J, Liao K-H, Tsai C-H, Chan C-H, Tsai C-F, et al. Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2014;34:857-869.
44. Martnez-Ramos R, Garća-Lozano J-R, Lucena J-M, Castillo-Palma M-J, Garća-Herná ndez F, Rodrguez M-C, Nunez-Roldá n A, Gonzá lez-Escribano M-F. Differential expression pattern of microRNAs in CD41 and CD191 cells from asymptomatic patients with systemic lupus erythematosus. Lupus 2014;23:353-359.
45. Suá rez Y, Wang C, Manes TD, Pober JS. Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 2010;184:21-25.
46. Sun F, Wang J, Pan Q, Yu Y, Zhang Y, Wan Y, Wang J, Li X, Hong A. Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun 2009;380:660-665.
47. Xi S, Yang M, Tao Y, Xu H, Shan J, Inchauste S, Zhang M, Mercedes L, Hong JA, Rao M, et al. Cigarette smoke induces C/EBP-b-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One 2010;5:e13764.
48. Augoff K, McCue B, Plow EF, Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012;11:5.
49. Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, Schmittgen TD. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 2008;14:35-42.
50. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010;120: 1298-1309.
51. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001;19:623-655.
52. Adib-Conquy M, Pedron T, Petit-Bertron A-F, Tabary O, Corvol H, Jacquot J, Clé ment A, Cavaillon J-M. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 2008;14:36-44.
53. Burden RE, Snoddy P, Buick RJ, Johnston JA, Walker B, Scott CJ. Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment. Mol Cancer Ther 2008;7:538-547.